ArticleFrontiers in immunology2020

Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

Bárbara Soria-Juan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.